STRATTERA Side Effects

6836381-9 | Neutropenia
on Jun 30, 2010 Male patient from CANADA , 15 years of age, was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Strattera dosage: 60 Mg, Unk.

6836371-6 | Depressed Mood, Nervousness, Onychophagia, Oppositional Defiant Disorder, Suicidal Ideation, Weight Decreased
Patient was taking Strattera (View Usage). Patient had the following side effects: depressed mood, nervousness, onychophagia, oppositional defiant disorder, suicidal ideation, weight decreased on Jun 30, 2010 from SPAIN Additional patient health information: Male patient , weighting 83.78 lb, was diagnosed with attention deficit/hyperactivity disorder, lung disorder, eye disorder and. Strattera dosage: 25 Mg, Daily (1/d). During the same period patient was treated with PULMICORT (Unk, As Required) (View Pulmicort Review and Pulmicort Label ), TERBASMIN (Unk, As Required) (View Terbasmin Review and Terbasmin Label ), FML (View Fml Review and Fml Label ).

6818724-5 | Feeling Jittery
Adverse event was reported on Jun 22, 2010 by a Female patient taking Strattera (View Usage) (Dosage: ) . Location: SOUTH AFRICA , child 10 years of age, After Strattera was administered, patient had the following side effects: feeling jittery. Patient was hospitalized.

6809331-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Jun 18, 2010 Male patient from UNITED STATES , child 12 years of age, weighting 105.0 lb, was diagnosed with attention deficit/hyperactivity disorder, convulsion, pain (What is pain?), anxiety (What is anxiety?), precocious puberty, insomnia, constipation (What is constipation?) and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Strattera dosage: 40 Mg, Unk. During the same period patient was treated with FELBATOL (View Felbatol Review and Felbatol Label ), MINOCYCLINE (View Minocycline Review and Minocycline Label ), CLONAZEPAM (0.25 Mg, Unk) (View Clonazepam Review and Clonazepam Label ), LUPRON DEPOT (View Lupron Depot Review and Lupron Depot Label ), MELATONIN (View Melatonin Review and Melatonin Label ), MIRALAX (View Miralax Review and Miralax Label ), VYVANSE (View Vyvanse Review and Vyvanse Label ).


6809327-7 | Jaundice
on Jun 20, 2010 Male patient from IRELAND , child 10 years of age, weighting 68.34 lb, was treated with Strattera (View Usage). Patient had the following side effects: jaundice (What is jaundice?). Strattera dosage: 18 Mg, Daily (1/d).

6803726-5 | Intraocular Pressure Increased, Off Label Use, Visual Acuity Reduced
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: intraocular pressure increased, off label use, visual acuity reduced on Jun 15, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 110.2 lb, was diagnosed with tic (What is tic?) and. Strattera dosage: Unk, Unk.

6803665-X | Aggression, Anhedonia, Depression, Suicidal Behaviour, Suicidal Ideation
Adverse event was reported on Jun 15, 2010 by a Male patient taking Strattera (View Usage) (Dosage: ) . Location: AUSTRALIA , weighting 50.71 lb, Patient experienced the following unwanted or unexpected effects: aggression, anhedonia, depression (What is depression?), suicidal behaviour, suicidal ideation.

6790810-8 | Asthenia, Atrial Fibrillation, Fatigue, Joint Swelling, Palpitations, Ventricular Extrasystoles
on Jun 11, 2010 Male patient from UNITED STATES , 20 years of age, weighting 445.3 lb, was treated with Strattera (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), fatigue, joint swelling, palpitations, ventricular extrasystoles. Strattera dosage: 25 Mg, Daily (1/d). During the same period patient was treated with ADVIL COLD AND SINUS (View Advil Cold And Sinus Review and Advil Cold And Sinus Label ), CENTRUM PERFORMANCE (View Centrum Performance Review and Centrum Performance Label ). Patient was hospitalized.

6790761-9 | Electrocardiogram Qt Prolonged, Heart Rate Increased
on Jun 10, 2010 Male patient from UNITED STATES , child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: electrocardiogram qt prolonged, heart rate increased. Strattera dosage: 60 Mg, Daily (1/d). During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ).

6790760-7 | Electrocardiogram Qt Prolonged, Heart Rate Increased, Off Label Use
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, heart rate increased, off label use on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 60 Mg, Daily (1/d). During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ).

6786747-0 | Conduct Disorder, Self Injurious Behaviour
Adverse event was reported on Jun 10, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 60 Mg, Daily (1/d)) was diagnosed with mineral supplementation and. Location: TURKEY , 13 years of age, weighting 112.4 lb, Patient had the following side effects: conduct disorder, self injurious behaviour. During the same period patient was treated with FERRO SANOL (Unk Unk, Daily (1/d)) (View Ferro Sanol Review and Ferro Sanol Label ).

6784187-1 | Pancreatitis
on Jun 08, 2010 Male patient from UNITED STATES , child 11 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: pancreatitis. Strattera dosage: .

6782702-5 | Left Ventricular Failure
on Jun 08, 2010 Male patient from UNITED STATES , 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: left ventricular failure. Strattera dosage: . Patient was hospitalized.

6780257-2 | Abdominal Pain, Blood Bilirubin Increased, Vomiting
Patient was taking Strattera (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood bilirubin increased, vomiting on Jun 07, 2010 from SLOVENIA Additional patient health information: Male patient , 13 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: .

6780256-0 | Body Height Increased, Weight Increased
Adverse event was reported on Jun 07, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 80 Mg, Daily (1/d)) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , child 12 years of age, After Strattera was administered, patient had the following side effects: body height increased, weight increased. During the same period patient was treated with EQUASYM (40 Mg, Daily (1/d)) (View Equasym Review and Equasym Label ).

6780023-8 | Intentional Self-injury
on Jun 07, 2010 Female patient from AUSTRALIA , child 12 years of age, was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: intentional self-injury. Strattera dosage: .

6772890-9 | Aggression, Anger, Homicide, Irritability, Mental Disorder, Mood Altered, Poisoning, Social Avoidant Behaviour, Suicide Attempt
on Jun 03, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: aggression, anger, homicide, irritability, mental disorder, mood altered, poisoning (What is poisoning?), social avoidant behaviour, suicide attempt. Strattera dosage: . Patient was hospitalized.

6772872-7 | Amoebiasis
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: amoebiasis on Jun 04, 2010 from PHILIPPINES Additional patient health information: Female patient , child 6 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 10 Mg, Daily (1/d). Patient was hospitalized.

6772783-7 | Atrial Septal Defect, Cerebrovascular Accident
Adverse event was reported on Jun 03, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 40 Mg, Daily (1/d)) . Location: CANADA , 16 years of age, Patient experienced the following unwanted or unexpected effects: atrial septal defect, cerebrovascular accident. Patient was hospitalized.

6772779-5 | Gastritis
on Jun 03, 2010 Male patient from MEXICO , child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: gastritis. Strattera dosage: . Patient was hospitalized.

6757026-2 | Anorgasmia, Disturbance In Sexual Arousal, Ejaculation Disorder, Erectile Dysfunction
on May 24, 2010 Male patient from UNITED STATES , 54 years of age, weighting 189.6 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: anorgasmia, disturbance in sexual arousal, ejaculation disorder, erectile dysfunction (What is erectile dysfunction?). Strattera dosage: Unk, Unk. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

6757024-9 | Gastrointestinal Tube Insertion, Hospitalisation
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal tube insertion, hospitalisation on May 24, 2010 from UNITED STATES Additional patient health information: Female patient , 20 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 10 Mg, Daily (1/d). Patient was hospitalized.

6753919-0 | Gastroenteritis, Subcutaneous Abscess, Superinfection
Adverse event was reported on May 21, 2010 by a Male patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: BELGIUM , weighting 66.14 lb, Patient had the following side effects: gastroenteritis (What is gastroenteritis?), subcutaneous abscess, superinfection.

6753918-9 | Epistaxis, Off Label Use
on May 20, 2010 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with tourette's disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: epistaxis, off label use. Strattera dosage: .

6753911-6 | Acute Hepatic Failure, Cholestatic Liver Injury, Toxic Encephalopathy
on May 20, 2010 Male patient from TURKEY , weighting 132.3 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, cholestatic liver injury, toxic encephalopathy. Strattera dosage: 40 Mg, Start Dose. During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ). Patient was hospitalized.

6753904-9 | Epistaxis, Haemoglobin Decreased, Headache, Hormone Level Abnormal, Insomnia, Menorrhagia, Off Label Use
Patient was taking Strattera (View Usage). Patient had the following side effects: epistaxis, haemoglobin decreased, headache (What is headache?), hormone level abnormal, insomnia, menorrhagia, off label use on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 128.0 lb, was diagnosed with tourette's disorder and. Strattera dosage: 40 Mg, Each Evening. During the same period patient was treated with LOVAZA (View Lovaza Review and Lovaza Label ), IRON (View Iron Review and Iron Label ).

6753850-0 | Glaucoma
Adverse event was reported on May 20, 2010 by a Female patient taking Strattera (View Usage) (Dosage: ) was diagnosed with attention deficit/hyperactivity disorder and. Location: DENMARK , child 8 years of age, After Strattera was administered, patient had the following side effects: glaucoma (What is glaucoma?).

6753846-9 | Liver Function Test Abnormal, Liver Injury
on May 20, 2010 Male patient from AUSTRALIA , 33 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal, liver injury. Strattera dosage: .

6752506-8 | Abnormal Behaviour, Anger, Anxiety, Educational Problem, Headache, Irritability
on Jun 01, 2010 Male patient from UNITED STATES , 19 years of age, weighting 200.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: abnormal behaviour, anger, anxiety (What is anxiety?), educational problem, headache (What is headache?), irritability. Strattera dosage: 1 Tablet Every Morning Po.

6748190-X | Agitation, Electrocardiogram Qt Prolonged, Heart Rate Increased, Off Label Use, Somnolence
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: agitation, electrocardiogram qt prolonged, heart rate increased, off label use, somnolence on May 17, 2010 from GERMANY Additional patient health information: Male patient , child 7 years of age, was diagnosed with asperger's disorder and. Strattera dosage: . During the same period patient was treated with RISPERIDONE (0.25 Mg, Unk) (View Risperidone Review and Risperidone Label ).

6744326-5 | Epstein-barr Virus Infection
Adverse event was reported on May 14, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 18 Mg, Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 11 years of age, weighting 77.99 lb, Patient experienced the following unwanted or unexpected effects: epstein-barr virus infection. Patient was hospitalized.

6740386-6 | Hospitalisation, Rash
on May 13, 2010 Female patient from MEXICO , 20 years of age, was diagnosed with impulsive behaviour and was treated with Strattera (View Usage). Patient had the following side effects: hospitalisation, rash (What is rash?). Strattera dosage: 80 Mg, Daily (1/d). Patient was hospitalized.

6739526-4 | Asthma
on May 13, 2010 Male patient from UNITED STATES , child 10 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: asthma (What is asthma?). Strattera dosage: 25 Mg, Unk. During the same period patient was treated with CONCERTA (1 D/f, Unk) (View Concerta Review and Concerta Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6739049-2 | Gastritis
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis on May 12, 2010 from MEXICO Additional patient health information: Male patient , child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: . Patient was hospitalized.

6739047-9 | Abdominal Pain, Lymphocyte Count Increased, Monocyte Count Increased, Priapism, Red Blood Cell Count Decreased
Adverse event was reported on May 12, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 1 D/f, Unk) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , weighting 70.99 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), lymphocyte count increased, monocyte count increased, priapism, red blood cell count decreased. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), MIRALAX (View Miralax Review and Miralax Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), TYLENOL /SCH/ (View Tylenol /sch/ Review and Tylenol /sch/ Label ), SINGULAIR (5 Mg, Unk) (View Singulair Review and Singulair Label ), DIGESTIVES ENZYMES (1 D/f, 2/d) (View Digestives Enzymes Review and Digestives Enzymes Label ), MULTI VITAMIN (1 D/f, Daily (1/d)) (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6738750-4 | Left Ventricular Failure
on May 11, 2010 Male patient from UNITED STATES , 13 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: left ventricular failure. Strattera dosage: . Patient was hospitalized.

6736783-5 | Aggression, Anger, Homicide, Irritability, Mental Disorder, Mood Altered, Social Avoidant Behaviour, Suicide Attempt
on May 10, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anger, homicide, irritability, mental disorder, mood altered, social avoidant behaviour, suicide attempt. Strattera dosage: . Patient was hospitalized.

6736720-3 | Epistaxis
Patient was taking Strattera (View Usage). Patient had the following side effects: epistaxis on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 17 years of age, weighting 92.00 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: 40 Mg 1 Po.

6736341-2 | Grand Mal Convulsion
Adverse event was reported on May 20, 2010 by a Female patient taking Strattera (View Usage) (Dosage: Strattera 100mg Daily P.o.) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , weighting 135.4 lb, After Strattera was administered, patient had the following side effects: grand mal convulsion.

6732845-7 | Chest Pain, Electrocardiogram Abnormal
on May 06, 2010 Female patient from UNITED STATES , child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), electrocardiogram abnormal. Strattera dosage: 40 Mg, Daily (1/d). During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), CONCERTA (View Concerta Review and Concerta Label ).

6732840-8 | Acute Hepatic Failure, Cholestatic Liver Injury, Toxic Encephalopathy
on May 07, 2010 Male patient from TURKEY , weighting 132.3 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: acute hepatic failure, cholestatic liver injury, toxic encephalopathy. Strattera dosage: 40 Mg, Start Dose. During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ). Patient was hospitalized.

6732794-4 | Hepatic Enzyme Increased, Pancreatitis
Patient was taking Strattera (View Usage). After Strattera was administered, patient had the following side effects: hepatic enzyme increased, pancreatitis on May 06, 2010 from GERMANY Additional patient health information: Male patient , 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: . Patient was hospitalized.

6731705-5 | Suicidal Ideation
Adverse event was reported on May 18, 2010 by a Male patient taking Strattera (View Usage) (Dosage: 1 Capsule Daily Po) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 10 years of age, weighting 75.00 lb, Patient experienced the following unwanted or unexpected effects: suicidal ideation.

6722524-4 | Bicuspid Aortic Valve, Chest Pain
on Apr 29, 2010 Female patient from UNITED STATES , child 11 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). Patient had the following side effects: bicuspid aortic valve, chest pain (What is chest pain?). Strattera dosage: 10 Mg, Daily (1/d).

6722514-1 | Cyanosis
on Apr 30, 2010 Male patient from GERMANY , 16 years of age, was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: cyanosis. Strattera dosage: . Patient was hospitalized.

6722138-6 | Arrhythmia, Blood Bilirubin Increased, Dizziness, Gilbert's Syndrome
Patient was taking Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood bilirubin increased, dizziness (What is dizziness?), gilbert's syndrome on Apr 28, 2010 from SPAIN Additional patient health information: Male patient , weighting 48.50 lb, was diagnosed with attention deficit/hyperactivity disorder and. Strattera dosage: .

6716540-6 | Loss Of Consciousness, Overdose, Vomiting
Adverse event was reported on Apr 26, 2010 by a Female patient taking Strattera (View Usage) (Dosage: 1 D/f, Unk) . Location: UNITED STATES , child 12 years of age, Patient had the following side effects: loss of consciousness, overdose, vomiting. During the same period patient was treated with TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

6716517-0 | Blood Glucose Decreased, Hunger, Hyperhidrosis
on Mar 31, 2010 Male patient from UNITED STATES , 37 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Strattera (View Usage). After Strattera was administered, patient had the following side effects: blood glucose decreased, hunger, hyperhidrosis. Strattera dosage: 25 Mg, Unk. During the same period patient was treated with HUMULIN R (View Humulin R Review and Humulin R Label ), LANTUS (View Lantus Review and Lantus Label ), NORCO (View Norco Review and Norco Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ACCUPRIL (View Accupril Review and Accupril Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), VISTARIL (View Vistaril Review and Vistaril Label ).

6712514-X | Decreased Appetite, Dry Mouth, Food Craving, Weight Decreased
on May 05, 2010 Female patient from UNITED STATES , 61 years of age, weighting 111.0 lb, was diagnosed with traumatic brain injury (What is traumatic brain injury?) and was treated with Strattera (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dry mouth, food craving, weight decreased. Strattera dosage: 75 Mg Daily Oral. During the same period patient was treated with NADOLOL (View Nadolol Review and Nadolol Label ), CRESTOR (View Crestor Review and Crestor Label ).

6712283-3 | Glaucoma
Patient was taking Strattera (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?) on Apr 23, 2010 from ROMANIA Additional patient health information: Male patient , weighting 74.96 lb, was diagnosed with attention deficit/hyperactivity disorder, learning disability and. Strattera dosage: 25 Mg, Unk. During the same period patient was treated with GINKGO BILOBA (80 Mg, Daily (1/d)) (View Ginkgo Biloba Review and Ginkgo Biloba Label ). Patient was hospitalized.